Pain, reflux, urination, and hot flashes can also fragment sleep
oral formulation (Rybelsus) also available Lixisenatide (Lyxumia) once-daily injection NICE guidance for type 2 diabetes (NG28) recommends GLP-1 receptor agonists in specific circumstances: typically as a third-line option when other treatments haven't achieved adequate glycaemic control, particularly in people with a BMI 35 kg/m (adjusted for ethnicity), or for whom weight loss would benefit other obesity-related comorbidities, or for whom insulin would have significant occupational implications
Evidence Disclaimer: No published clinical trials were located on the finished Patchie GLP-1 patch product itself
I do fully understand, though, that there will be situations in which using them makes some sense
"They're in a prime position to provide companion lifestyle intervention, which overwhelmingly all employers, all clinicians, believe that this is a necessity," he said
CrossRef Heterogeneity of hepatic macrophages in MASLD/MASH: Lipid-associated programs, molecular mechanisms, spatial niches, and therapeutic implications Kaipeng Hu, Siyuan Liu, Shuyan Sheng, Shaobo Zhang, Binghua Li, Beicheng Sun, Anliang Xia iLIVER .2026
